This inventor holds 5 USPTO granted patents and 10 published patent applications. Top assignee: Hoffmann-La Roche Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dmitry Mazunin: Innovator in Pharmaceutical Chemistry
Introduction
Dmitry Mazunin is a notable inventor based in Grenzach-Wyhlen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. With a total of 5 patents to his name, Mazunin's work has the potential to impact various therapeutic areas.
Latest Patents
Among his latest patents, one includes the invention of amino-pyrimidine cyclo-amides. This invention provides novel compounds characterized by a specific general formula, which includes compositions and methods for using these compounds as ATX inhibitors. Another significant patent involves substituted amino-pyrimidines, which also presents novel compounds with defined characteristics, along with their compositions and methods of use.
Career Highlights
Dmitry Mazunin is currently employed at Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at this esteemed organization allows him to collaborate with other talented professionals and contribute to groundbreaking research and development.
Collaborations
Some of his notable coworkers include Luke Green and Hasane Ratni. Their collaboration fosters an environment of innovation and creativity, enhancing the potential for new discoveries in their field.
Conclusion
Dmitry Mazunin's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile